Table 13Body of evidence for subcutaneous immunotherapy affecting combined rhinitis (with or without asthma) symptom-medication scores

StudyAllergenComparatorNumber of ParticipantsRisk of BiasDirection of ChangeDirectnessMagnitude of Effect
Van Metre 198067RagweedSCIT
Placebo
39Medium+DirectModerate
Van Metre 198168RagweedSCIT
Placebo
44HighDirectCould not determine*
Weyer 1981105Grass mixSCIT
Placebo
33High+DirectStrong
Shamji, 201280Grass mixSCIT 100,000
SCIT 10,000
Placebo
221Medium+DirectModerate
Tabar 200796AlternariaSCIT
Placebo
28LowDirectWeak
Chakraborty 2006107Date treesSCIT
Placebo
35Medium+DirectStrong

+ = positive; − = negative; SCIT = subcutaneous immunotherapy

*

Not enough data were provided in the article to calculate the magnitude of effect.

From: Results

Cover of Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review
Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review [Internet].
Comparative Effectiveness Reviews, No. 111.
Lin SY, Erekosima N, Suarez-Cuervo C, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.